ibaf 2025
International Biotechnology Achievement Forum 2025 - Riyadh
Towards the Kingdom's Global Biotechnology and Innovation Leadership
14 DECEMBER 2025. KACST
IBAF'2025
The International Biotechnology Achievement Forum (IBAF’2025) marks the culmination of a 2.5-month intensive biotechnology startup program “Biotechnology Venture Readiness Program 2025”, celebrating the collective achievements of Saudi and international biotechnology ecosystem professionals – Mentors, Lecturers, and Startup Founders from the Kingdom and abroad. It represents an important national milestone in building a strong, globally competitive biotechnology and life sciences innovation sector.
In dedication to advancing deep-tech innovation in Saudi Arabia, and in alignment with the national vision to establish the Kingdom as a global biotechnology and innovation hub, this event introduced the first Saudi-trained international biotech and life sciences innovation cohort.
The Forum is organized in accordance with international venture-readiness and demo-day standards.
Forum Moments
International biotechnology achievement forum 2025 - riyadh
Forum Speakers
distinguished lecturers & mentors of bvrp'2025
Forum Heroes - Startups
founders of the top startups, bvrp'2025
Immunora
(🇸🇦 Saudi Arabia)
Dr. Mohammed Alassiri, Founder of Immunora. Immonora is developing innovative therapies for inflammatory diseases, combining novel peptide drugs with CAR-T cell therapy to restore immune balance.
Opportunity Health
(🇪🇸 Spain)
Mr. Nicolás López de Aguileta Castaño, CTO and Mr. Germán Alejandro Sánchez Martín, Founder & CEO. Opportunity Health is developing Yarnasa, an automatic and self-applicable medical device designed to clear airway obstructions within seconds during choking emergencies.
Speratum Biopharma
(🇺🇸 United States)
Dr. Fadi Abdel, Chief Development & Operations Officer. Speratum Biopharma is developing a next-generation RNAi therapeutic platform that restores tumor suppressor function and targets over 150 oncogenic pathways using a computerized engineered RNA molecule delivered through a cold chain free polymeric system designed for solid tumors.
MedSyntra
(🇱🇹 Lithuania)
Ms. Asta Ratkeviciene, Co-Founder & CEO. MedSyntra delivers a sovereign radiology data infrastructure designed to support Saudi Arabia's Vision 2030 ambition to build one of the world's most advanced digital health ecosystems.
BioFiber Solutions
(🇸🇦 Saudi Arabia)
Ms. Dunia Alzahrani, Co-Founder and COO. BioFiber Solutions specializes in developing a nanotechnology-driven wound-care solution that enhances the healing of diabetic foot wounds through an active therapeutic nanofiber dressing.
Augmented Research
(🇸🇦 Saudi Arabia)
Dr. Alya Redhwan, Founder and CEO. Augmented Research is building the Amazon of life science products, revolutionizing procurement by offering researchers, scientists, and lab managers a centralized online marketplace.
VuEssence
(🇺🇸 Unites States)
Dr. Maha Sallam, Founder and President. VuEssence ( United States) leverages gene expression information measured in blood to understand and distinguish between serious conditions that have overlapping clinical symptoms.
GENABU
(🇪🇸 Spain)
Dr. Mazahir T. Hasan, Co-Founder. GENABU is a gene therapy startup with the mission to deliver novel approaches for fighting CNS diseases with synthetic biology.
Erada for Healthy Life
(🇸🇦 Saudi Arabia)
Mr. Omar Kandil, Founder & CEO. Erada is a pioneering Saudi digital health platform offering AI-driven personalized nutrition and wellness solutions integrated with obesity genetic testing to empower healthier lifestyles across the Gulf region.
PrintyMed
(🇱🇻 Latvia)
Ms. Jekaterina Romanova, Founder & CEO. PrintyMed is a biotech company producing nature-identical, medical-grade spider silk proteins via a proprietary bacterial bioreactor process, creating revolutionary biomaterials for advanced medical applications.
Neo Alchemist Bio
(🇮🇹 Italy)
Dr. Massimo Serra, Founder and Head of Research. Neo Alchemist Bio develops a new generation of Health-Agri-Biotech solutions with a near-zero environmental footprint, which directly address: the rising prevalence of chronic diseases, high dependency on imported medical supplies, and acute environmental stress impacting food and water sources.
Valere Therapeutics
(🇸🇦 Saudi Arabia)
Dr. Meshael Alturki, Co-Founder and CEO. Valere Therapeutics, develops precision immunotherapies to address urgent gaps in breast cancer care, particularly in the Gulf region. A scalable platform targets immune resistance in solid tumours.
Organizers & Partners
International Biotechnology achievement forum 2025
Saudi Biotechnology Accelerator
Pioneering Riyadh-based Saudi Biotechnology Accelerator, advancing biotech, healthtech and life sciences innovators’ journey, and helping to excel in the markets, while actively contributing to the Saudi innovation ecosystem